Name
Recruiting and Retaining Study Participants Breakout: Democratizing Clinical Trials – Bringing the Trial to the Patient
Date & Time
Tuesday, October 18, 2022, 10:45 AM - 11:30 AM
Location Name
Wilshire AB
Description

For many clinical research staff members, recruiting participants for a study poses a challenge – sometimes a bigger challenge than conducting the actual trial itself. Delays in recruiting participants will by default extend the study’s timeline, ultimately delaying the treatment’s arrival on the market at the end of the trial.

What are the changes we need to consider to engage a diverse group of patients of all ages and stages and then keep them engaged for the entire trial? Social media has become a key tool but there isn’t just one place to post. What are some of the methodologies that work best? Our first topic will explore how social media should be targeted to the right demographic, especially age.

Our second session will address the lack of diversity in many trials, as well as the patient burden and techniques that are being explored to bring the trial to the patient and help patients to choose their own journey.  

Our last session will discuss some of the approaches that are being used to keep the patients engaged and involved because if the trial isn’t completed and the patient drops or is lost to follow-up, the ultimate value of the product’s development is impacted. Keeping patients engaged until the end of their participation is critical, and we will explore how research sites and technology can support that goal.

Laura Halloran Owen Garrick R'Kes Starling
Learning Objectives
  • Define democratization of clinical trials and unveil practical examples of accessible trials 
  • Assess different trial models that bring more optionality, flexibility, and choice to patients 
  • Determine the biggest obstacles that hinder democratizing clinical trials and address potential solutions 
This Module is Eligible for
ACRP CE Points, CCB Credits, CLE Credits, CME Credits, CNE Credits
ACRP CE Points
0.75